NCT06658587View on ClinicalTrials.gov

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2027

Conditions
Cholangiocarcinoma
Interventions
DIAGNOSTIC_TEST

No interventions

No interventions

Trial Locations (1)

510220

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT06658587 - A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma | Biotech Hunter | Biotech Hunter